Nothing Special   »   [go: up one dir, main page]

US20120326084A1 - Liquid-crystalline medium - Google Patents

Liquid-crystalline medium Download PDF

Info

Publication number
US20120326084A1
US20120326084A1 US13/582,543 US201113582543A US2012326084A1 US 20120326084 A1 US20120326084 A1 US 20120326084A1 US 201113582543 A US201113582543 A US 201113582543A US 2012326084 A1 US2012326084 A1 US 2012326084A1
Authority
US
United States
Prior art keywords
atoms
denotes
compounds
liquid
another
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US13/582,543
Other versions
US8877092B2 (en
Inventor
Melanie Klasen-Memmer
Volker Reiffenrath
Konstantin Schneider
Andreas Waechtler
Elvira Montenegro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Assigned to MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG reassignment MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KLASEN-MEMMER, MELANIE, MONTENEGRO, ELVIRA, REIFFENRATH, VOLKER, SCHNEIDER, KONSTANTIN, WAECHTLER, ANDREAS
Publication of US20120326084A1 publication Critical patent/US20120326084A1/en
Application granted granted Critical
Publication of US8877092B2 publication Critical patent/US8877092B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/063Non-steroidal liquid crystal compounds containing one non-condensed saturated non-aromatic ring, e.g. cyclohexane ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/065Non-steroidal liquid crystal compounds containing one non-condensed unsaturated non-aromatic ring, e.g. cyclohexene ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3048Cyclohexane rings in which at least two rings are linked by a carbon chain containing carbon to carbon double bonds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition

Definitions

  • the invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I,
  • Media of this type can be used, in particular, for electro-optical displays having active-matrix addressing based on the ECB effect and for IPS (in-plane switching) displays or FFS (fringe field switching) displays.
  • IPS in-plane switching
  • FFS far field switching
  • VAN vertical aligned nematic displays
  • MVA multi-domain vertical alignment
  • MVA multi-domain vertical alignment
  • PVA patterned vertical alignment, for example: Kim, Sang Soo, paper 15.4: “Super PVA Sets New State-of-the-Art for LCD-TV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 760 to 763)
  • ASV advanced super view, for example: Shigeta, Mitzuhiro and Fukuoka, Hirofumi, paper 15.2: “Development of High Quality LCDTV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp.
  • LC phases which have to satisfy a multiplicity of requirements.
  • Particularly important here are chemical resistance to moisture, air and physical influences, such as heat, infrared, visible and ultraviolet radiation and direct and alternating electric fields.
  • LC phases are required to have a liquid-crystalline mesophase in a suitable temperature range and low viscosity.
  • None of the hitherto-disclosed series of compounds having a liquid-crystalline mesophase includes a single compound which meets all these requirements. Mixtures of two to 25, preferably three to 18, compounds are therefore generally prepared in order to obtain substances which can be used as LC phases. However, it has not been possible to prepare optimum phases easily in this way since no liquid-crystal materials having significantly negative dielectric anisotropy and adequate long-term stability were hitherto available.
  • Matrix liquid-crystal displays are known.
  • Non-linear elements which can be used for individual switching of the individual pixels are, for example, active elements (i.e. transistors).
  • active matrix is then used, where a distinction can be made between two types:
  • the electro-optical effect used is usually dynamic scattering or the guest-host effect.
  • the use of single-crystal silicon as substrate material restricts the display size, since even modular assembly of various part-displays results in problems at the joints.
  • the electro-optical effect used is usually the TN effect.
  • TFTs comprising compound semiconductors, such as, for example, CdSe, or TFTs based on polycrystalline or amorphous silicon.
  • CdSe compound semiconductors
  • TFTs based on polycrystalline or amorphous silicon The latter technology is being worked on intensively worldwide.
  • the TFT matrix is applied to the inside of one glass plate of the display, while the other glass plate carries the transparent counterelectrode on its inside. Compared with the size of the pixel electrode, the TFT is very small and has virtually no adverse effect on the image.
  • This technology can also be extended to fully colour-capable displays, in which a mosaic of red, green and blue filters is arranged in such a way that a filter element is opposite each switchable pixel.
  • MLC displays of this type are particularly suitable for TV applications (for example pocket TVs) or for high-information displays in automobile or aircraft construction.
  • TV applications for example pocket TVs
  • high-information displays in automobile or aircraft construction Besides problems regarding the angle dependence of the contrast and the response times, difficulties also arise in MLC displays due to insufficiently high specific resistance of the liquid-crystal mixtures [TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORI-MACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, September 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, pp. 141 ff., Paris; STROMER, M., Proc.
  • VA displays have significantly better viewing-angle dependencies and are therefore principally used for televisions and monitors.
  • frame rates image change frequency/repetition rates
  • the properties such as, for example, the low-temperature stability, must not be impaired.
  • the invention is based on the object of providing liquid-crystal mixtures, in particular for monitor and TV applications, which are based on the ECB effect or on the IPS or FFS effect, which do not have the above-mentioned disadvantages or only do so to a reduced extent.
  • it must be ensured for monitors and televisions that they also operate at extremely high and extremely low temperatures and at the same time have short response times and at the same time have improved reliability behaviour, in particular have no or significantly reduced image sticking after long operating times.
  • liquid-crystal mixtures preferably VA mixtures, which have short response times, at the same time good phase properties and good low-temperature behaviour.
  • the invention thus relates to a liquid-crystalline medium which comprises at least one compound of the formula I.
  • the present invention likewise relates to compounds of the formula I.
  • the mixtures according to the invention preferably exhibit very broad nematic phase ranges having clearing points ⁇ 70° C., preferably ⁇ 75° C., in particular ⁇ 80° C., very favourable values for the capacitive threshold, relatively high values for the holding ratio and at the same time very good low-temperature stabilities at ⁇ 20° C. and ⁇ 30° C., as well as very low rotational viscosities and short response times.
  • the mixtures according to the invention are furthermore distinguished by the fact that, in addition to the improvement in the rotational viscosity ⁇ 1 , relatively high values of the elastic constant K 33 for improving the response times can be observed.
  • the ring A preferably denotes a cyclohexane ring.
  • R 1 and R 1 * each, independently of one another, preferably denote alkyl, in particular n-C 3 H 7 , i-C 3 H 7 , n-C 4 H 9 , i-C 4 H 9 , t-C 4 H 9 , C 5 H 11 , C 6 H 13 , C 7 H 15 , and alkenyl, preferably CH 2 ⁇ CH, CH 3 CH ⁇ CH, CH 3 CH ⁇ CHCH 2 , CF 2 ⁇ CH, and furthermore alkoxy, preferably OC 2 H 5 , OC 3 H 7 , OC 4 H 9 , OC 5 H 11 , OC 6 H 13 , furthermore alkenyloxy, in particular OCH 2 CH ⁇ CH 2 , OCH 2 CH ⁇ CHCH 3 , OCH 2 CH ⁇ CHC 2 H 5 .
  • Preferred compounds of the formula I are the compounds of the formulae I-1 to I-8:
  • the mixture according to the invention very particularly preferably comprises at least one compound of the formula I-1 or I-5.
  • the compounds of the formulae I-1 and 1-5 are preferably compounds I-1a, I-1b and I-5a:
  • n and m each, independently of one another, denote 1, 2, 3, 4, 5, 6, 7 or 8.
  • the compounds of the formula I can be prepared, for example, as follows:
  • 1,4-Diisopropylcyclohexane can be prepared, for example, as described in Liberman; Wasina; Kasanskii: Doklady Chemistry; 132; 1960; 463; ISSN: 0012-5008; DANKAS; Doklady Akademii Nauk SSSR; 132; 1960; 130, or van Bekkum, H. et al. Recueil des Travaux Chimiques des Pays-Bas; English; 89; 1970; 913-919; ISSN: 0165-0513.
  • 1,4-Dialkenylcyclohexane compounds are known, for example, from JP H10-218801.
  • the media according to the invention preferably comprise one, two, three, four or more, preferably one, two or three, compounds of the formula I.
  • the compounds of the formula I are preferably employed in the liquid-crystalline medium in amounts of ⁇ 1% by weight, preferably ⁇ 5% by weight, based on the mixture as a whole. Particular preference is given to liquid-crystalline media which comprise 2-15% by weight of one or more compounds of the formula I.
  • mixtures according to the invention preferably comprise
  • mixtures according to the invention which comprise the following mixture concepts:
  • the invention furthermore relates to an electro-optical display having active-matrix addressing based on the ECB, VA, PS-VA, IPS or FFS effect, characterised in that it contains, as dielectric, a liquid-crystalline medium according to one or more of Claims 1 to 9 .
  • the liquid-crystalline medium according to the invention preferably has a nematic phase from ⁇ 20° C. to ⁇ 70° C., particularly preferably from ⁇ 3° C. to ⁇ 80° C., very particularly preferably from ⁇ 40° C. to ⁇ 90° C.
  • the expression “have a nematic phase” here means on the one hand that no smectic phase and no crystallisation are observed at low temperatures at the corresponding temperature and on the other hand that clearing still does not occur on heating from the nematic phase.
  • the investigation at low temperatures is carried out in a flow viscometer at the corresponding temperature and checked by storage in test cells having a layer thickness corresponding to the electro-optical use for at least 100 hours. If the storage stability at a temperature of ⁇ 20° C. in a corresponding test cell is 1000 h or more, the medium is referred to as stable at this temperature. At temperatures of ⁇ 30° C. and ⁇ 40° C., the corresponding times are 500 h and 250 h respectively. At high temperatures, the clearing point is measured by conventional methods in capillaries.
  • the liquid-crystal mixture preferably has a nematic phase range of at least 60 K and a flow viscosity ⁇ 20 of at most 30 mm 2 ⁇ s ⁇ 1 at 20° C.
  • the values of the birefringence ⁇ n in the liquid-crystal mixture are generally between 0.07 and 0.16, preferably between 0.08 and 0.12.
  • the liquid-crystal mixture according to the invention has a ⁇ of ⁇ 0.5 to ⁇ 8.0, in particular ⁇ 2.5 to ⁇ 6.0, where ⁇ denotes the dielectric anisotropy.
  • the rotational viscosity ⁇ 1 at 20° C. is preferably ⁇ 165 mPa ⁇ s, in particular ⁇ 140 mPa ⁇ s.
  • the liquid-crystal media according to the invention have relatively low values for the threshold voltage (V 0 ). They are preferably in the range from 1.7 V to 3.0 V, particularly preferably ⁇ 2.5 V and very particularly preferably ⁇ 2.3 V.
  • threshold voltage relates to the capacitive threshold (V 0 ), also known as the Freedericks threshold, unless explicitly indicated otherwise.
  • liquid-crystal media according to the invention have high values for the voltage holding ratio in liquid-crystal cells.
  • liquid-crystal media having a low addressing voltage or threshold voltage exhibit a lower voltage holding ratio than those having a higher addressing voltage or threshold voltage and vice versa.
  • dielectrically positive compounds denotes compounds having a ⁇ >1.5
  • dielectrically neutral compounds denotes those having ⁇ 1.5 ⁇ 1.5
  • dielectrically negative compounds denotes those having ⁇ 1.5.
  • the dielectric anisotropy of the compounds is determined here by dissolving 10% of the compounds in a liquid-crystalline host and determining the capacitance of the resultant mixture in at least one test cell in each case having a layer thickness of 20 ⁇ m with homeotropic and with homogeneous surface alignment at 1 kHz.
  • the measurement voltage is typically 0.5 V to 1.0 V, but is always lower than the capacitive threshold of the respective liquid-crystal mixture investigated.
  • the mixtures according to the invention are suitable for all VA-TFT applications, such as, for example, VAN, MVA, (S)-PVA, ASV, PSA (polymer sustained VA) and PS-VA (polymer stabilized VA). They are furthermore suitable for IPS (in-plane switching) and FFS (fringe field switching) applications having negative ⁇ .
  • the nematic liquid-crystal mixtures in the displays according to the invention generally comprise two components A and B, which themselves consist of one or more individual compounds.
  • Component A has significantly negative dielectric anisotropy and gives the nematic phase a dielectric anisotropy of ⁇ 0.5.
  • it preferably comprises the compounds of the formulae IIA, IIB and/or IIC, furthermore compounds of the formula III.
  • the proportion of component A is preferably between 45 and 100%, in particular between 60 and 100%.
  • one (or more) individual compound(s) which has (have) a value of ⁇ 0.8 is (are) preferably selected. This value must be more negative, the smaller the proportion A in the mixture as a whole.
  • Component B has pronounced nematogeneity and a flow viscosity of not greater than 30 mm 2 ⁇ s ⁇ 1 , preferably not greater than 25 mm 2 ⁇ s ⁇ 1 , at 20° C.
  • Particularly preferred individual compounds in component B are extremely low-viscosity nematic liquid crystals having a flow viscosity of not greater than 18 mm 2 ⁇ s ⁇ 1 , preferably not greater than 12 mm 2 ⁇ s ⁇ 1 , at 20° C.
  • Component B is monotropically or enantiotropically nematic, has no smectic phases and is able to prevent the occurrence of smectic phases down to very low temperatures in liquid-crystal mixtures. For example, if various materials of high nematogeneity are added to a smectic liquid-crystal mixture, the nematogeneity of these materials can be compared through the degree of suppression of smectic phases that is achieved.
  • the mixture may optionally also comprise a component C, comprising compounds having a dielectric anisotropy of ⁇ 21.5.
  • a component C comprising compounds having a dielectric anisotropy of ⁇ 21.5.
  • positive compounds are generally present in a mixture of negative dielectric anisotropy in amounts of ⁇ 20% by weight, based on the mixture as a whole.
  • liquid-crystal phases may also comprise more than 18 components, preferably 18 to 25 components.
  • the phases preferably comprise 4 to 15, in particular 5 to 12, and particularly preferably ⁇ 10, compounds of the formulae IIA, IIB and/or IIC and optionally III.
  • the other constituents are preferably selected from nematic or nematogenic substances, in particular known substances, from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl cyclohexanecarboxylates, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-biscyclohexylbiphenyls or cyclohexylpyrimidines, phenyl- or cyclohexyldioxanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acid esters.
  • L and E each denote a carbo- or heterocyclic ring system from the group formed by 1,4-disubstituted benzene and cyclohexane rings, 4,4′-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3-dioxane rings, 2,6-disubstituted naphthalene, di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline, G denotes —CH ⁇ CH— —N(O) ⁇ N—
  • R 20 and R 21 are different from one another, one of these radicals usually being an alkyl or alkoxy group.
  • Other variants of the proposed substituents are also common. Many such substances or also mixtures thereof are commercially available. All these substances can be prepared by methods known from the literature.
  • VA, IPS or FFS mixture according to the invention may also comprise compounds in which, for example, H, N, O, Cl and F have been replaced by the corresponding isotopes.
  • Polymerisable compounds so-called reactive mesogens (RMs), for example as disclosed in U.S. Pat. No. 6,861,107, may furthermore be added to the mixtures according to the invention in concentrations of preferably 0.12-5% by weight, particularly preferably 0.2-2% by weight, based on the mixture.
  • These mixtures may optionally also comprise an initiator, as described, for example, in U.S. Pat. No. 6,781,665.
  • the initiator for example Irganox-1076 from Ciba, is preferably added to the mixture comprising polymerisable compounds in amounts of 0-1%.
  • PS-VA polymer-stabilised VA modes
  • PSA polymer sustained VA
  • the polymerisable compounds are selected from the compounds of the formula M,
  • Particularly preferred compounds of the formula M are those in which
  • Suitable and preferred RMs for use in liquid-crystalline media and PS-VA displays or PSA displays according to the invention are selected, for example, from the following formulae:
  • Suitable polymerisable compounds are listed, for example, in Table D.
  • the liquid-crystalline media in accordance with the present application preferably comprise in total 0.1 to 10%, preferably 0.2 to 4.0%, particularly preferably 0.2 to 2.0%, of polymerisable compounds.
  • the mixtures according to the invention may furthermore comprise conventional additives, such as, for example, stabilisers, antioxidants, UV absorbers, nanoparticles, microparticles, etc.
  • the structure of the liquid-crystal displays according to the invention corresponds to the usual geometry, as described, for example, in EP-A 0 240 379.
  • the mixtures according to the invention preferably comprise one or more of the compounds from Table A indicated below.
  • liquid-crystal mixtures which can be used in accordance with the invention are prepared in a manner which is conventional per se.
  • the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing.
  • liquid-crystal phases according to the invention can be modified in such a way that they can be employed in any type of, for example, ECB, VAN, IPS, GH or ASM-VA LCD display that has been disclosed to date.
  • the dielectrics may also comprise further additives known to the person skilled in the art and described in the literature, such as, for example, UV absorbers, antioxidants, nanoparticles and free-radical scavengers.
  • further additives known to the person skilled in the art and described in the literature, such as, for example, UV absorbers, antioxidants, nanoparticles and free-radical scavengers.
  • 0-15% of pleochroic dyes, stabilisers or chiral dopants may be added.
  • Suitable stabilisers for the mixtures according to the invention are, in particular, those listed in Table B.
  • pleochroic dyes may be added, furthermore conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf., for example, Haller et al., Mol. Cryst. Liq. Cryst. Volume 24, pages 249-258 (1973)), may be added in order to improve the conductivity or substances may be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. Substances of this type are described, for example, in DE-A 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430 and 28 53 728.
  • Table B shows possible dopants which can be added to the mixtures according to the invention. If the mixtures comprise a dopant, it is employed in amounts of 0.01-4% by weight, preferably 0.1-1.0% by weight.
  • Stabilisers which can be added, for example, to the mixtures according to the invention in amounts of up to 10% by weight, based on the total amount of the mixture, preferably 0.01 to 6% by weight, in particular 0.1 to 3% by weight, are shown below in Table C.
  • Preferred stabilisers are, in particular, BHT derivatives, for example 2,6-di-tert-butyl-4-alkylphenols, and Tinuvin 770.
  • m.p. denotes the melting point and C denotes the clearing point of a liquid-crystalline substance in degrees Celsius; boiling points are denoted by b.p. Furthermore:
  • C denotes crystalline solid state
  • S denotes smectic phase (the index denotes the phase type)
  • N denotes nematic state
  • Ch denotes cholesteric phase
  • I denotes isotropic phase
  • T g denotes glass transition temperature. The number between two symbols indicates the conversion temperature in degrees Celsius.
  • the host mixture used for determination of the physical data of the compounds of the formula I is the commercial mixture ZLI-4792 (Merck KGaA).
  • the physical data of the compound to be investigated are obtained from the change in the dielectric constants of the host mixture after addition of the compound to be investigated and extrapolation to 100% of the compound employed. In general, 10% of the compound to be investigated are dissolved in the host mixture, depending on the solubility.
  • parts or percent data denote parts by weight or percent by weight.
  • the display used for measurement of the threshold voltage has two plane-parallel outer plates at a separation of 20 ⁇ m and electrode layers with overlying alignment layers of SE-1211 (Nissan Chemicals) on the insides of the outer plates, which effect a homeotropic alignment of the liquid crystals.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I,
Figure US20120326084A1-20121227-C00001
  • in which
  • R1, R1*, ring A have the meanings indicated in Claim 1,
  • and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PALC, FFS or IPS effect.

Description

  • The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I,
  • Figure US20120326084A1-20121227-C00002
  • in which
    • R1 and R1* each, independently of one another, denote an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by —C≡C—, —CF2O—, —CH═CH—,
  • Figure US20120326084A1-20121227-C00003
    •  —O—, —CO—O—, —O—CO— in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, and
    • ring A denotes a 1,4-cyclohexylene ring or 1,4-cyclohexenylene ring, in which, in addition, one or two CH2 groups may be replaced by —O— and/or —S—.
  • Media of this type can be used, in particular, for electro-optical displays having active-matrix addressing based on the ECB effect and for IPS (in-plane switching) displays or FFS (fringe field switching) displays.
  • The principle of electrically controlled birefringence, the ECB effect or also DAP (deformation of aligned phases) effect, was described for the first time in 1971 (M. F. Schieckel and K. Fahrenschon, “Deformation of nematic liquid crystals with vertical orientation in electrical fields”, Appl. Phys. Lett. 19 (1971), 3912). This was followed by papers by J. F. Kahn (Appl. Phys. Lett. 20 (1972), 1193) and G. Labrunie and J. Robert (J. Appl. Phys. 44 (1973), 4869).
  • The papers by J. Robert and F. Clerc (SID 80 Digest Techn. Papers (1980), 30), J. Duchene (Displays 7 (1986), 3) and H. Schad (SID 82 Digest Techn. Papers (1982), 244) showed that liquid-crystalline phases must have high values for the ratio of the elastic constants K3/K1, high values for the optical anisotropy Δn and values for the dielectric anisotropy of Δ∈≦−0.5 in order to be suitable for use in high-information display elements based on the ECB effect. Electro-optical display elements based on the ECB effect have a homeotropic edge alignment (VA technology=vertically aligned). Dielectrically negative liquid-crystal media can also be used in displays which use the so-called IPS or FFS effect.
  • Displays which use the ECB effect, as so-called VAN (vertically aligned nematic) displays, for example in the MVA (multi-domain vertical alignment, for example: Yoshide, H. et al., paper 3.1: “MVA LCD for Notebook or Mobile PCs . . . ”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book I, pp. 6 to 9, and Liu, C. T. et al., paper 15.1: “A 46-inch TFT-LCD HDTV Technology . . . ”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 750 to 753), PVA (patterned vertical alignment, for example: Kim, Sang Soo, paper 15.4: “Super PVA Sets New State-of-the-Art for LCD-TV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 760 to 763), ASV (advanced super view, for example: Shigeta, Mitzuhiro and Fukuoka, Hirofumi, paper 15.2: “Development of High Quality LCDTV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 754 to 757) modes, have established themselves as one of the three more recent types of liquid-crystal display that are currently the most important, in particular for television applications, besides IPS (inplane switching) displays (for example: Yeo, S. D., paper 15.3: “An LC Display for the TV Application”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 758 & 759) and the long-known TN (twisted nematic) displays. The technologies are compared in general form, for example, in Souk, Jun, SID Seminar 2004, seminar M-6: “Recent Advances in LCD Technology”, Seminar Lecture Notes, M-6/1 to M-6/26, and Miller, Ian, SID Seminar 2004, seminar M-7: “LCD-Television”, Seminar Lecture Notes, M-7/1 to M-7/32. Although the response times of modern ECB displays have already been significantly improved by addressing methods with overdrive, for example: Kim, Hyeon Kyeong et al., paper 9.1: “A 57-in. Wide UXGA TFT-LCD for HDTV Application”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book I, pp. 106 to 109, the achievement of video-compatible response times, in particular on switching of grey shades, is still a problem which has not yet been satisfactorily solved.
  • Industrial application of this effect in electro-optical display elements requires LC phases, which have to satisfy a multiplicity of requirements. Particularly important here are chemical resistance to moisture, air and physical influences, such as heat, infrared, visible and ultraviolet radiation and direct and alternating electric fields.
  • Furthermore, industrially usable LC phases are required to have a liquid-crystalline mesophase in a suitable temperature range and low viscosity.
  • None of the hitherto-disclosed series of compounds having a liquid-crystalline mesophase includes a single compound which meets all these requirements. Mixtures of two to 25, preferably three to 18, compounds are therefore generally prepared in order to obtain substances which can be used as LC phases. However, it has not been possible to prepare optimum phases easily in this way since no liquid-crystal materials having significantly negative dielectric anisotropy and adequate long-term stability were hitherto available.
  • Matrix liquid-crystal displays (MLC displays) are known. Non-linear elements which can be used for individual switching of the individual pixels are, for example, active elements (i.e. transistors). The term “active matrix” is then used, where a distinction can be made between two types:
    • 1. MOS (metal oxide semiconductor) transistors on a silicon wafer as substrate
    • 2. thin-film transistors (TFTs) on a glass plate as substrate.
  • In the case of type 1, the electro-optical effect used is usually dynamic scattering or the guest-host effect. The use of single-crystal silicon as substrate material restricts the display size, since even modular assembly of various part-displays results in problems at the joints.
  • In the case of the more promising type 2, which is preferred, the electro-optical effect used is usually the TN effect.
  • A distinction is made between two technologies: TFTs comprising compound semiconductors, such as, for example, CdSe, or TFTs based on polycrystalline or amorphous silicon. The latter technology is being worked on intensively worldwide.
  • The TFT matrix is applied to the inside of one glass plate of the display, while the other glass plate carries the transparent counterelectrode on its inside. Compared with the size of the pixel electrode, the TFT is very small and has virtually no adverse effect on the image. This technology can also be extended to fully colour-capable displays, in which a mosaic of red, green and blue filters is arranged in such a way that a filter element is opposite each switchable pixel.
  • The term MLC displays here covers any matrix display with integrated non-linear elements, i.e. besides the active matrix, also displays with passive elements, such as varistors or diodes (MIM=metal-insulator-metal).
  • MLC displays of this type are particularly suitable for TV applications (for example pocket TVs) or for high-information displays in automobile or aircraft construction. Besides problems regarding the angle dependence of the contrast and the response times, difficulties also arise in MLC displays due to insufficiently high specific resistance of the liquid-crystal mixtures [TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORI-MACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, September 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, pp. 141 ff., Paris; STROMER, M., Proc. Eurodisplay 84, September 1984: Design of Thin Film Transistors for Matrix Addressing of Television Liquid Crystal Displays, pp. 145 ff., Paris]. With decreasing resistance, the contrast of an MLC display deteriorates. Since the specific resistance of the liquid-crystal mixture generally drops over the life of an MLC display owing to interaction with the inside surfaces of the display, a high (initial) resistance is very important for displays that have to have acceptable resistance values over a long operating period.
  • There thus continues to be a great demand for MLC displays having very high specific resistance at the same time as a large working-temperature range, short response times and a low threshold voltage with the aid of which various grey shades can be produced.
  • The disadvantage of the frequently-used MLC-TN displays is due to their comparatively low contrast, the relatively high viewing-angle dependence and the difficulty of generating grey shades in these displays.
  • VA displays have significantly better viewing-angle dependencies and are therefore principally used for televisions and monitors. However, there continues to be a need here to improve the response times, in particular with respect to the use of televisions having frame rates (image change frequency/repetition rates) of greater than 60 Hz. At the same time, however, the properties, such as, for example, the low-temperature stability, must not be impaired.
  • The invention is based on the object of providing liquid-crystal mixtures, in particular for monitor and TV applications, which are based on the ECB effect or on the IPS or FFS effect, which do not have the above-mentioned disadvantages or only do so to a reduced extent. In particular, it must be ensured for monitors and televisions that they also operate at extremely high and extremely low temperatures and at the same time have short response times and at the same time have improved reliability behaviour, in particular have no or significantly reduced image sticking after long operating times.
  • Surprisingly, it is possible to improve the rotational viscosities and thus the response times if neutral compounds of the general formula I are used in liquid-crystal mixtures, in particular in LC mixtures having negative dielectric anisotropy, preferably for VA displays.
  • So-called monocyclic compounds (compounds having one ring) generally cannot be used in nematic liquid-crystal mixtures owing to their poor phase properties and low clearing points. However, the compounds of the formula I have, surprisingly, simultaneously very low rotational viscosities and high absolute values of the dielectric anisotropy. It is therefore possible to prepare liquid-crystal mixtures, preferably VA mixtures, which have short response times, at the same time good phase properties and good low-temperature behaviour.
  • The invention thus relates to a liquid-crystalline medium which comprises at least one compound of the formula I. The present invention likewise relates to compounds of the formula I.
  • The mixtures according to the invention preferably exhibit very broad nematic phase ranges having clearing points ≧70° C., preferably ≧75° C., in particular ≧80° C., very favourable values for the capacitive threshold, relatively high values for the holding ratio and at the same time very good low-temperature stabilities at −20° C. and −30° C., as well as very low rotational viscosities and short response times. The mixtures according to the invention are furthermore distinguished by the fact that, in addition to the improvement in the rotational viscosity γ1, relatively high values of the elastic constant K33 for improving the response times can be observed.
  • Some preferred embodiments of the mixtures according to the invention are indicated below.
  • In the compounds of the formula I, the ring A preferably denotes a cyclohexane ring.
  • In the compounds of the formula I, R1 and R1* each, independently of one another, preferably denote alkyl, in particular n-C3H7, i-C3H7, n-C4H9, i-C4H9, t-C4H9, C5H11, C6H13, C7H15, and alkenyl, preferably CH2═CH, CH3CH═CH, CH3CH═CHCH2, CF2═CH, and furthermore alkoxy, preferably OC2H5, OC3H7, OC4H9, OC5H11, OC6H13, furthermore alkenyloxy, in particular OCH2CH═CH2, OCH2CH═CHCH3, OCH2CH═CHC2H5.
  • Preferred compounds of the formula I are the compounds of the formulae I-1 to I-8:
  • Figure US20120326084A1-20121227-C00004
  • in which
    • alkyl and alkyl* each, independently of one another, denote a straight-chain or branched alkyl radical having 1-8 C atoms,
    • alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-8 C atoms,
    • alkoxy and alkoxy* each, independently of one another, denote a straight-chain alkoxy radical having 1-8 C atoms.
  • The mixture according to the invention very particularly preferably comprises at least one compound of the formula I-1 or I-5.
  • The compounds of the formulae I-1 and 1-5 are preferably compounds I-1a, I-1b and I-5a:
  • Figure US20120326084A1-20121227-C00005
  • where n and m each, independently of one another, denote 1, 2, 3, 4, 5, 6, 7 or 8.
  • The compounds of the formula I can be prepared, for example, as follows:
  • Figure US20120326084A1-20121227-C00006
  • where
    • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms.
  • 1,4-Diisopropylcyclohexane can be prepared, for example, as described in Liberman; Wasina; Kasanskii: Doklady Chemistry; 132; 1960; 463; ISSN: 0012-5008; DANKAS; Doklady Akademii Nauk SSSR; 132; 1960; 130, or van Bekkum, H. et al. Recueil des Travaux Chimiques des Pays-Bas; English; 89; 1970; 913-919; ISSN: 0165-0513.
  • 1,4-Dialkenylcyclohexane compounds are known, for example, from JP H10-218801.
  • The media according to the invention preferably comprise one, two, three, four or more, preferably one, two or three, compounds of the formula I.
  • The compounds of the formula I are preferably employed in the liquid-crystalline medium in amounts of ≧1% by weight, preferably ≧5% by weight, based on the mixture as a whole. Particular preference is given to liquid-crystalline media which comprise 2-15% by weight of one or more compounds of the formula I.
  • Preferred embodiments of the liquid-crystalline medium according to the invention are indicated below:
    • a) Liquid-crystalline medium which additionally comprises one or more compounds selected from the group of the compounds of the formulae IIA, IIB and IIC:
  • Figure US20120326084A1-20121227-C00007
      • in which
      • R2A, R2B and R2C each, independently of one another, denote H, an alkyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may be replaced by —O—, —S—,
  • Figure US20120326084A1-20121227-C00008
  • —C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another,
      • L1-4 each, independently of one another, denote F, Cl, CF3 or CHF2,
      • Z2 and Z2′ each, independently of one another, denote a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —CF═CF—, —CH═CHCH2O—,
      • p denotes 1 or 2,
      • q denotes 0 or 1, and
      • v denotes 1 to 6.
      • In the compounds of the formulae IIA and IIB, Z2 may have identical or different meanings. In the compounds of the formula IIB, Z2 and Z2′ may have identical or different meanings.
      • In the compounds of the formulae IIA, IIB and IIC, R2A, R2B and R2C each preferably denote alkyl having 1-6 C atoms, in particular CH3, C2H5, n-C3H7, n-C4H9, n-C5H11.
      • In the compounds of the formulae IIA and IIB, L1, L2, L3 and L4 preferably denote L=L2=F and L3=L4=F, furthermore L=F and L2=C1, L1=C1 and L2=F, L3=F and L4=C1, L3=C1 and L4=F. Z2 and Z2′ in the formulae IIA and IIB preferably each, independently of one another, denote a single bond, furthermore a —C2H4— bridge.
      • If in the formula IIB Z2=—C2H4—, Z2′ is preferably a single bond or, if Z2′=—C2H4—, Z2 is preferably a single bond. In the compounds of the formulae IIA and IIB, (O)CvH2v+1 preferably denotes OCvH2v+1, furthermore CVH2v+1. In the compounds of the formula IIC, (O)CvH2v+1 preferably denotes CvH2v+1. In the compounds of the formula IIC, L3 and L4 preferably each denote F.
      • Preferred compounds of the formulae IIA, IIB and IIC are indicated below:
  • Figure US20120326084A1-20121227-C00009
    Figure US20120326084A1-20121227-C00010
    Figure US20120326084A1-20121227-C00011
    Figure US20120326084A1-20121227-C00012
    Figure US20120326084A1-20121227-C00013
    Figure US20120326084A1-20121227-C00014
    Figure US20120326084A1-20121227-C00015
      • in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms.
      • Particularly preferred mixtures according to the invention comprise one or more compounds of the formulae IIA-2, IIA-8, IIA-14, IIA-29, IIA-35, IIB-2, IIB-11, IIB-16 and IIC-1.
      • The proportion of compounds of the formulae IIA and/or IIB in the mixture as a whole is preferably at least 20% by weight.
      • Particularly preferred media according to the invention comprise at least one compound of the formula IIC-1,
  • Figure US20120326084A1-20121227-C00016
      • in which alkyl and alkyl* have the meanings indicated above, preferably in amounts of >3% by weight, in particular >5% by weight and particularly preferably 5-25% by weight.
    • b) Liquid-crystalline medium which additionally comprises one or more compounds of the formula III,
  • Figure US20120326084A1-20121227-C00017
      • in which
      • R31 and R32 each, independently of one another, denote a straight-chain alkyl, alkoxyalkyl or alkoxy radical having up to 12 C atoms, and
  • Figure US20120326084A1-20121227-C00018
  • denotes
  • Figure US20120326084A1-20121227-C00019
      • Z3 denotes a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —C4H8—, —CF═CF—.
      • Preferred compounds of the formula III are indicated below:
  • Figure US20120326084A1-20121227-C00020
      • in which
      • alkyl and
      • alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms.
      • The medium according to the invention preferably comprises at least one compound of the formula IIIa and/or formula IIIb.
      • The proportion of compounds of the formula III in the mixture as a whole is preferably at least 5% by weight.
    • c) Liquid-crystalline medium additionally comprising a compound of the formula
  • Figure US20120326084A1-20121227-C00021
      • preferably in total amounts of ≧5% by weight, in particular ≧10% by weight.
      • Particular preference is given to mixtures according to the invention comprising the compound
  • Figure US20120326084A1-20121227-C00022
      • preferably in total amounts of >30% by weight.
      • Preference is furthermore given to mixtures according to the invention comprising the compound
  • Figure US20120326084A1-20121227-C00023
      • d) Liquid-crystalline medium which additionally comprises one or more tetracyclic compounds of the formulae
  • Figure US20120326084A1-20121227-C00024
      • in which
      • R7-10 each, independently of one another, have one of the meanings indicated for R2A in Claim 2, and
      • w and x each, independently of one another, denote 1 to 6.
    • e) Liquid-crystalline medium which additionally comprises one or more compounds of the formulae Y-1 to Y-6,
  • Figure US20120326084A1-20121227-C00025
      • in which R14-R19 each, independently of one another, denote an alkyl or alkoxy radical having 1-6 C atoms; z and m each, independently of one another, denote 1-6; x denotes 0, 1, 2 or 3.
      • The medium according to the invention particularly preferably comprises one or more compounds of the formulae Y-1 to Y-6, preferably in amounts of ≧5% by weight.
    • f) Liquid-crystalline medium additionally comprising one or more fluorinated terphenyls of the formulae T-1 to T-21,
  • Figure US20120326084A1-20121227-C00026
    Figure US20120326084A1-20121227-C00027
    Figure US20120326084A1-20121227-C00028
      • in which
      • R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms, and m=0, 1, 2, 3, 4, 5 or 6 and n denotes 0, 1, 2, 3 or 4.
      • R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy.
      • The medium according to the invention preferably comprises the terphenyls of the formulae T-1 to T-21 in amounts of 2-30% by weight, in particular 5-20% by weight.
      • Particular preference is given to compounds of the formulae T-1, T-2, T-20 and T-21. In these compounds, R preferably denotes alkyl, furthermore alkoxy, each having 1-5 C atoms. In the compounds of the formula T-20, R preferably denotes alkyl or alkenyl, in particular alkyl. In the compound of the formula T-21, R preferably denotes alkyl.
      • The terphenyls are preferably employed in the mixtures according to the invention if the Δn value of the mixture is to be ≧0.1. Preferred mixtures comprise 2-20% by weight of one or more terphenyl compounds selected from the group of the compounds T-1 to T-21.
    • g) Liquid-crystalline medium additionally comprising one or more biphenyls of the formulae B-1 to B-3,
  • Figure US20120326084A1-20121227-C00029
      • in which
      • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and
      • alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms.
      • The proportion of the biphenyls of the formulae B-1 to B-3 in the mixture as a whole is preferably at least 3% by weight, in particular ≧5% by weight.
      • Of the compounds of the formulae B-1 to B-3, the compounds of the formula B-2 are particularly preferred.
      • Particularly preferred biphenyls are
  • Figure US20120326084A1-20121227-C00030
      • in which alkyl* denotes an alkyl radical having 1-6 C atoms. The medium according to the invention particularly preferably comprises one or more compounds of the formulae B-1a and/or B-2c.
    • h) Liquid-crystalline medium comprising at least one compound of the formulae Z-1 to Z-7,
  • Figure US20120326084A1-20121227-C00031
      • in which R and alkyl have the meanings indicated above.
    • i) Liquid-crystalline medium comprising at least one compound of the formulae O-1 to O-16,
  • Figure US20120326084A1-20121227-C00032
    Figure US20120326084A1-20121227-C00033
      • in which R1 and R2 have the meanings indicated for R2A. R1 and R2 preferably each, independently of one another, denote straight-chain alkyl.
      • Preferred media comprise one or more compounds of the formulae O-1, O-3, O-4, O-5, O-9, O-13, O-14, O-15 and/or O-16.
      • Mixtures according to the invention very particularly preferably comprise the compounds of the formula O-9, O-15 and/or O-16, in particular in amounts of 5-30%.
      • Preferred compounds of the formulae O-15 and O-16 are indicated below:
  • Figure US20120326084A1-20121227-C00034
      • The medium according to the invention particularly preferably comprises the tricyclic compounds of the formula O-15a and/or of the formula O-15b in combination with one or more bicyclic compounds of the formulae O-16a to O-16d. The total proportion of the compounds of the formulae O-15a and/or O-15b in combination with one or more compounds selected from the bicyclic compounds of the formulae O-16a to O-16d is 5-40%, very particularly preferably 15-35%.
      • Very particularly preferred mixtures comprise compounds O-15a and O-16a:
  • Figure US20120326084A1-20121227-C00035
      • Compounds O-15a and O-16a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
      • Very particularly preferred mixtures comprise compounds O-15b and O-16a:
  • Figure US20120326084A1-20121227-C00036
      • Compounds O-15b and O-16a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
      • Very particularly preferred mixtures comprise the following three compounds:
  • Figure US20120326084A1-20121227-C00037
      • Compounds O-15a, O-15b and O-16a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
    • j) Preferred liquid-crystalline media according to the invention comprise one or more substances which contain a tetrahydronaphthyl or naphthyl unit, such as, for example, the compounds of the formulae N-1 to N-5,
  • Figure US20120326084A1-20121227-C00038
      • in which R1N and R2N each, independently of one another, have the meanings indicated for R2A, preferably denote straight-chain alkyl, straight-chain alkoxy or straight-chain alkenyl, and
      • Z1 and Z2 each, independently of one another, denote —C2H4—, —CH═CH—, —(CH2)4—, —(CH2)3O—, —O(CH2)3—, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —CF═CF—, —CF═CH—, —CH═CF—, —CF2O—, —OCF2—, —CH2— or a single bond.
    • k) Preferred mixtures comprise one or more compounds selected from the group of the difluorodibenzochroman compounds of the formula BC, chromans of the formula CR, fluorinated phenanthrenes of the formulae PH-1 and PH-2, fluorinated dibenzofurans of the formula BF,
  • Figure US20120326084A1-20121227-C00039
      • in which
      • RB1, RB2, RCR1, RCR2, R1, R2 each, independently of one another, have the meaning of R2A. C is 0, 1 or 2.
      • The mixtures according to the invention preferably comprise the compounds of the formulae BC, CR, PH-1, PH-2 and/or BF in amounts of 3 to 20% by weight, in particular in amounts of 3 to 15% by weight. Particularly preferred compounds of the formulae BC and CR are the compounds BC-1 to BC-7 and CR-1 to CR-5,
  • Figure US20120326084A1-20121227-C00040
    Figure US20120326084A1-20121227-C00041
      • in which
      • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and
      • alkenyl and
      • alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms.
      • Very particular preference is given to mixtures comprising one, two or three compounds of the formula BC-2.
    • l) Preferred mixtures comprise one or more indane compounds of the formula In,
  • Figure US20120326084A1-20121227-C00042
      • in which
      • R11, R12,
      • R13 each, independently of one another, denote a straight-chain alkyl, alkoxy, alkoxyalkyl or alkenyl radical having 1-6 C atoms,
      • R12 and R13 additionally denote halogen, preferably F,
  • Figure US20120326084A1-20121227-C00043
  • denotes
  • Figure US20120326084A1-20121227-C00044
      • i denotes 0, 1 or 2.
      • Preferred compounds of the formula In are the compounds of the formulae In-1 to In-16 indicated below:
  • Figure US20120326084A1-20121227-C00045
    Figure US20120326084A1-20121227-C00046
      • Particular preference is given to the compounds of the formulae In-1, In-2, In-3 and In-4.
      • The compounds of the formula In and the sub-formulae In-1 to In-16 are preferably employed in the mixtures according to the invention in concentrations ≧5% by weight, in particular 5-30% by weight and very particularly preferably 5-25% by weight.
    • m) Preferred mixtures additionally comprise one or more compounds of the formulae L-1 to L-11,
  • Figure US20120326084A1-20121227-C00047
    Figure US20120326084A1-20121227-C00048
      • in which
      • R, R1 and R2 each, independently of one another, have the meanings indicated for R2A in claim 2, and alkyl denotes an alkyl radical having 1-6 C atoms. s denotes 1 or 2.
      • Particular preference is given to the compounds of the formulae L-1 and L-4, in particular L-4.
      • The compounds of the formulae L-1 to L-11 are preferably employed in concentrations of 5-50% by weight, in particular 5-40% by weight and very particularly preferably 10-40% by weight.
  • Particularly preferred mixture concepts are indicated below: (the acronyms used are explained in Table A. n and m here each denote, independently of one another, 1-6).
  • The mixtures according to the invention preferably comprise
      • the compound of the formula I in which L=L2=F and R1=R1*=alkoxy,
      • CPY-n-Om, in particular CPY-2-O2, CPY-3-O2 and/or CPY-5-O2, preferably in concentrations >5%, in particular 10-30%, based on the mixture as a whole,
        and/or
      • CY-n-Om, preferably CY-3-O2, CY-3-O4, CY-5-O2 and/or CY-5-O4, preferably in concentrations >5%, in particular 15-50%, based on the mixture as a whole,
        and/or
      • CCY-n-Om, preferably CCY-3-O1, CCY-4-O2, CCY-3-O2, CCY-3-O3 and/or CCY-5-O2, preferably in concentrations >5%, in particular 10-30%, based on the mixture as a whole,
        and/or
      • CLY-n-Om, preferably CLY-2-O4, CLY-3-O2 and/or CLY-3-O3, preferably in concentrations >5%, in particular 10-30%, based on the mixture as a whole,
        and/or
      • CK-n-F, preferably CK-3-F, CK-4-F and/or CK-5-F, preferably in concentrations of >5%, in particular 5-25%, based on the mixture as a whole.
  • Preference is furthermore given to mixtures according to the invention which comprise the following mixture concepts:
  • (n and m each denote, independently of one another, 1-6.)
      • CPY-n-Om and CY-n-Om, preferably in concentrations of 10-80%, based on the mixture as a whole,
        and/or
      • CPY-n-Om and CK-n-F, preferably in concentrations of 10-70%, based on the mixture as a whole,
        and/or
      • CPY-n-Om and CLY-n-Om, preferably in concentrations of 10-80%, based on the mixture as a whole.
  • The invention furthermore relates to an electro-optical display having active-matrix addressing based on the ECB, VA, PS-VA, IPS or FFS effect, characterised in that it contains, as dielectric, a liquid-crystalline medium according to one or more of Claims 1 to 9.
  • The liquid-crystalline medium according to the invention preferably has a nematic phase from ≦−20° C. to ≧70° C., particularly preferably from ≦−3° C. to ≧80° C., very particularly preferably from ≦−40° C. to ≧90° C.
  • The expression “have a nematic phase” here means on the one hand that no smectic phase and no crystallisation are observed at low temperatures at the corresponding temperature and on the other hand that clearing still does not occur on heating from the nematic phase. The investigation at low temperatures is carried out in a flow viscometer at the corresponding temperature and checked by storage in test cells having a layer thickness corresponding to the electro-optical use for at least 100 hours. If the storage stability at a temperature of −20° C. in a corresponding test cell is 1000 h or more, the medium is referred to as stable at this temperature. At temperatures of −30° C. and −40° C., the corresponding times are 500 h and 250 h respectively. At high temperatures, the clearing point is measured by conventional methods in capillaries.
  • The liquid-crystal mixture preferably has a nematic phase range of at least 60 K and a flow viscosity ν20 of at most 30 mm2·s−1 at 20° C.
  • The values of the birefringence Δn in the liquid-crystal mixture are generally between 0.07 and 0.16, preferably between 0.08 and 0.12.
  • The liquid-crystal mixture according to the invention has a Δ∈ of −0.5 to −8.0, in particular −2.5 to −6.0, where Δ∈ denotes the dielectric anisotropy. The rotational viscosity γ1 at 20° C. is preferably ≦165 mPa·s, in particular ≦140 mPa·s.
  • The liquid-crystal media according to the invention have relatively low values for the threshold voltage (V0). They are preferably in the range from 1.7 V to 3.0 V, particularly preferably ≦2.5 V and very particularly preferably ≦2.3 V.
  • For the present invention, the term “threshold voltage” relates to the capacitive threshold (V0), also known as the Freedericks threshold, unless explicitly indicated otherwise.
  • In addition, the liquid-crystal media according to the invention have high values for the voltage holding ratio in liquid-crystal cells.
  • In general, liquid-crystal media having a low addressing voltage or threshold voltage exhibit a lower voltage holding ratio than those having a higher addressing voltage or threshold voltage and vice versa.
  • For the present invention, the term “dielectrically positive compounds” denotes compounds having a Δ∈>1.5, the term “dielectrically neutral compounds” denotes those having −1.5≦Δ∈≦1.5 and the term “dielectrically negative compounds” denotes those having Δ∈<−1.5. The dielectric anisotropy of the compounds is determined here by dissolving 10% of the compounds in a liquid-crystalline host and determining the capacitance of the resultant mixture in at least one test cell in each case having a layer thickness of 20 μm with homeotropic and with homogeneous surface alignment at 1 kHz. The measurement voltage is typically 0.5 V to 1.0 V, but is always lower than the capacitive threshold of the respective liquid-crystal mixture investigated.
  • All temperature values indicated for the present invention are in ° C.
  • The mixtures according to the invention are suitable for all VA-TFT applications, such as, for example, VAN, MVA, (S)-PVA, ASV, PSA (polymer sustained VA) and PS-VA (polymer stabilized VA). They are furthermore suitable for IPS (in-plane switching) and FFS (fringe field switching) applications having negative Δ∈.
  • The nematic liquid-crystal mixtures in the displays according to the invention generally comprise two components A and B, which themselves consist of one or more individual compounds.
  • Component A has significantly negative dielectric anisotropy and gives the nematic phase a dielectric anisotropy of ≦−0.5. Besides one or more compounds of the formula I, it preferably comprises the compounds of the formulae IIA, IIB and/or IIC, furthermore compounds of the formula III.
  • The proportion of component A is preferably between 45 and 100%, in particular between 60 and 100%.
  • For component A, one (or more) individual compound(s) which has (have) a value of Δ∈≦−0.8 is (are) preferably selected. This value must be more negative, the smaller the proportion A in the mixture as a whole.
  • Component B has pronounced nematogeneity and a flow viscosity of not greater than 30 mm2·s−1, preferably not greater than 25 mm2·s−1, at 20° C.
  • Particularly preferred individual compounds in component B are extremely low-viscosity nematic liquid crystals having a flow viscosity of not greater than 18 mm2·s−1, preferably not greater than 12 mm2·s−1, at 20° C.
  • Component B is monotropically or enantiotropically nematic, has no smectic phases and is able to prevent the occurrence of smectic phases down to very low temperatures in liquid-crystal mixtures. For example, if various materials of high nematogeneity are added to a smectic liquid-crystal mixture, the nematogeneity of these materials can be compared through the degree of suppression of smectic phases that is achieved.
  • The mixture may optionally also comprise a component C, comprising compounds having a dielectric anisotropy of Δ∈≦21.5. These so-called positive compounds are generally present in a mixture of negative dielectric anisotropy in amounts of ≦20% by weight, based on the mixture as a whole.
  • A multiplicity of suitable materials is known to the person skilled in the art from the literature. Particular preference is given to compounds of the formula III.
  • In addition, these liquid-crystal phases may also comprise more than 18 components, preferably 18 to 25 components.
  • Besides one or more compounds of the formula I, the phases preferably comprise 4 to 15, in particular 5 to 12, and particularly preferably <10, compounds of the formulae IIA, IIB and/or IIC and optionally III.
  • Besides compounds of the formula I and the compounds of the formulae IIA, IIB and/or IIC and optionally III, other constituents may also be present, for example in an amount of up to 45% of the mixture as a whole, but preferably up to 35%, in particular up to 10%.
  • The other constituents are preferably selected from nematic or nematogenic substances, in particular known substances, from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl cyclohexanecarboxylates, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-biscyclohexylbiphenyls or cyclohexylpyrimidines, phenyl- or cyclohexyldioxanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acid esters.
  • The most important compounds which are suitable as constituents of liquid-crystal phases of this type can be characterised by the formula IV

  • R20-L-G-E-R21  IV
  • in which L and E each denote a carbo- or heterocyclic ring system from the group formed by 1,4-disubstituted benzene and cyclohexane rings, 4,4′-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3-dioxane rings, 2,6-disubstituted naphthalene, di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline,
    G denotes —CH═CH— —N(O)═N—
      • —CH═CQ- —CH═N(O)—
      • —C≡C— —CH2—CH2
      • —CO—O— —CH2—O—
      • —CO—S— —CH2—S—
      • —CH═N— —COO-Phe-COO—
      • —CF2O— —CF═CF—
      • —OCF2— —OCH2
      • —(CH2)4— —(CH2)3O—
        or a C—C single bond, Q denotes halogen, preferably chlorine, or —CN, and R20 and R21 each denote alkyl, alkenyl, alkoxy, alkoxyalkyl or alkoxycarbonyloxy having up to 18, preferably up to 8, carbon atoms, or one of these radicals alternatively denotes CN, NC, NO2, NCS, CF3, SF5, OCF3, F, Cl or Br.
  • In most of these compounds, R20 and R21 are different from one another, one of these radicals usually being an alkyl or alkoxy group. Other variants of the proposed substituents are also common. Many such substances or also mixtures thereof are commercially available. All these substances can be prepared by methods known from the literature.
  • It goes without saying for the person skilled in the art that the VA, IPS or FFS mixture according to the invention may also comprise compounds in which, for example, H, N, O, Cl and F have been replaced by the corresponding isotopes.
  • Polymerisable compounds, so-called reactive mesogens (RMs), for example as disclosed in U.S. Pat. No. 6,861,107, may furthermore be added to the mixtures according to the invention in concentrations of preferably 0.12-5% by weight, particularly preferably 0.2-2% by weight, based on the mixture. These mixtures may optionally also comprise an initiator, as described, for example, in U.S. Pat. No. 6,781,665. The initiator, for example Irganox-1076 from Ciba, is preferably added to the mixture comprising polymerisable compounds in amounts of 0-1%. Mixtures of this type can be used for so-called polymer-stabilised VA modes (PS-VA) or PSA (polymer sustained VA), in which polymerisation of the reactive mesogens is intended to take place in the liquid-crystalline mixture. The prerequisite for this is that the liquid-crystal mixture does not itself comprise any polymerisable components.
  • In a preferred embodiment of the invention, the polymerisable compounds are selected from the compounds of the formula M,

  • RMa-AM1-(ZM1-AM2)m1-RMb  M
  • in which the individual radicals have the following meanings:
    • RMa and RMb each, independently of one another, denote P, P-Sp-, H, halogen, SF5, NO2, an alkyl, alkenyl or alkynyl group, where at least one of the radicals RMa and RMb preferably denotes or contains a group P or P-Sp-,
    • P denotes a polymerisable group,
    • Sp denotes a spacer group or a single bond,
    • AM1 and AM2 each, independently of one another, denote an aromatic, heteroaromatic, alicyclic or heterocyclic group, preferably having 4 to 25 ring atoms, preferably C atoms, which may also encompass or contain fused rings, and which may optionally be mono- or polysubstituted by L,
    • L denotes P, P-Sp-, OH, CH2OH, F, Cl, Br, I, —CN, —NO2, —NCO, —NCS, —OCN, —SCN, —C(═O)N(Rx)2, —C(═O)Y1, —C(═O)Rx, —N(Rx)2, optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-, preferably P, P-Sp-, H, OH, CH2OH, halogen, SF5, NO2, an alkyl, alkenyl or alkynyl group,
    • Y1 denotes halogen,
    • ZM1 denotes —O—, —S—, —CO—, —CO—O—, —OCO—, —O—CO—O—, —OCH2—, —CH2O—, —SCH2—, —CH2S—, —CF2O—, —OCF2—, —CF2S—, —SCF2—, —(CH2)n1—, —CF2CH2—, —CH2CF2—, —(CF2)n1—, —CH═CH—, —CF═CF—, —C≡C—, —CH═CH—, —COO—, —OCO—CH═CH—, CR0R00 or a single bond,
    • R0 and R00 each, independently of one another, denote H or alkyl having 1 to 12 C atoms,
    • Rx denotes P, P-Sp-, H, halogen, straight-chain, branched or cyclic alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may be replaced by —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms,
    • m1 denotes 0, 1, 2, 3 or 4, and
    • n1 denotes 1, 2, 3 or 4,
      where at least one, preferably one, two or three, particularly preferably one or two, from the group RMa, RMb and the substituents L present denotes a group P or P-Sp- or contains at least one group P or P-Sp-.
  • Particularly preferred compounds of the formula M are those in which
    • RMa and RMb each, independently of one another, denote P, P-Sp-, H, F, Cl, Br, I, —CN, —NO2, —NCO, —NCS, —OCN, —SCN, SF5 or straight-chain or branched alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by —C(R0)═C(R0)—, —C≡C—, —N(R00)—, —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, Br, I, CN, P or P-Sp-, where at least one of the radicals RMa and RMb preferably denotes or contains a group P or P-Sp-,
    • AM1 and AM2 each, independently of one another, denote 1,4-phenylene, naphthalene-1,4-diyl, naphthalene-2,6-diyl, phenanthrene-2,7-diyl, anthracene-2,7-diyl, fluorene-2,7-diyl, coumarine, flavone, where, in addition, one or more CH groups in these groups may be replaced by N, cyclohexane-1,4-diyl, in which, in addition, one or more non-adjacent CH2 groups may be replaced by O and/or S, 1,4-cyclohexenylene, bicyclo[1.1.1]-pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, piperidine-1,4-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, indane-2,5-diyl or octahydro-4,7-methanoindane-2,5-diyl, where all these groups may be unsubstituted or mono- or polysubstituted by L,
    • L denotes P, P-Sp-, OH, CH2OH, F, Cl, Br, I, —CN, —NO2, —NCO, —NCS, —OCN, —SCN, —C(═O)N(Rx)2, —C(═O)Y1, —C(═O)Rx, —N(Rx)2, optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-,
    • P denotes a polymerisable group,
    • Y1 denotes halogen,
    • Rx denotes P, P-Sp-, H, halogen, straight-chain, branched or cyclic alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may be replaced by —O—, —S—, —CO—, —CO—O—, —O—CO—, —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms.
  • Very particular preference is given to compounds of the formula M in which one of RMa and RMb or both denote(s) P or P-Sp-.
  • Suitable and preferred RMs for use in liquid-crystalline media and PS-VA displays or PSA displays according to the invention are selected, for example, from the following formulae:
  • Figure US20120326084A1-20121227-C00049
    Figure US20120326084A1-20121227-C00050
    Figure US20120326084A1-20121227-C00051
    Figure US20120326084A1-20121227-C00052
  • in which the individual radicals have the following meanings:
    • P1 and P2 each, independently of one another, denote a polymerisable group, preferably having one of the meanings indicated above and below for P, particularly preferably an acrylate, methacrylate, fluoroacrylate, oxetane, vinyloxy or epoxy group,
    • Sp1 and Sp2 each, independently of one another, denote a single bond or a spacer group, preferably having one of the meanings indicated above and below for Sp, and particularly preferably —(CH2)p1—, —(CH2)p1—O—, —(CH2)p1—CO—O— or —(CH2)p1—O—CO—O—, in which p1 is an integer from 1 to 12, and where the linking of the last-mentioned groups to the adjacent ring takes place via the O atom, where one of the radicals P1-Sp1- and P2-Sp2- may also denote Raa,
    • Raa denotes H, F, Cl, CN or straight-chain or branched alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by —C(R0)═C(R00)—, —C≡C—, —N(R0)—, —O—, —S—, —CO, —CO—O—, —O—CO—, —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by F, Cl, CN or P1-Sp1-, particularly preferably straight-chain or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl or alkylcarbonyloxy having 1 to 12 C atoms (where the alkenyl and alkynyl radicals have at least two C atoms and the branched radicals have at least three C atoms),
    • R0, R00 each, independently of one another and on each occurrence identically or differently, denote H or alkyl having 1 to 12 C atoms,
    • Ry and Rz each, independently of one another, denote H, F, CH3 or CF3,
    • ZM1 denotes —O—, —CO—, —C(RyRz)— or —CF2CF2—,
    • ZM2 and ZM3 each, independently of one another, denote —CO—O—, —O—CO—, —CH2O—, —OCH2—, —CF2O—, —OCF2— or —(CH2)n—, where n is 2, 3 or 4,
    • L on each occurrence, identically or differently, denotes F, Cl, CN, or straight-chain or branched, optionally mono- or polyfluorinated alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl or alkylcarbonyloxy having 1 to 12 C atoms, preferably F,
    • L′ and L″ each, independently of one another, denote H, F or Cl,
    • r denotes 0, 1, 2, 3 or 4,
    • s denotes 0, 1, 2 or 3,
    • t denotes 0, 1 or 2, and
    • x denotes 0 or 1.
  • Suitable polymerisable compounds are listed, for example, in Table D.
  • The liquid-crystalline media in accordance with the present application preferably comprise in total 0.1 to 10%, preferably 0.2 to 4.0%, particularly preferably 0.2 to 2.0%, of polymerisable compounds.
  • Particular preference is given to the polymerisable compounds of the formula M.
  • The mixtures according to the invention may furthermore comprise conventional additives, such as, for example, stabilisers, antioxidants, UV absorbers, nanoparticles, microparticles, etc.
  • The structure of the liquid-crystal displays according to the invention corresponds to the usual geometry, as described, for example, in EP-A 0 240 379.
  • The following examples are intended to explain the invention without limiting it. Above and below, percent data denote percent by weight; all temperatures are indicated in degrees Celsius.
  • Throughout the patent application, 1,4-cyclohexylene rings and 1,4-phenylene rings are depicted as follows:
  • Figure US20120326084A1-20121227-C00053
  • Besides the compounds of the formulae IIA and/or IIB and/or IIC, one or more compounds of the formula I, the mixtures according to the invention preferably comprise one or more of the compounds from Table A indicated below.
  • TABLE A
    Figure US20120326084A1-20121227-C00054
    Figure US20120326084A1-20121227-C00055
    Figure US20120326084A1-20121227-C00056
    Figure US20120326084A1-20121227-C00057
    Figure US20120326084A1-20121227-C00058
    Figure US20120326084A1-20121227-C00059
    Figure US20120326084A1-20121227-C00060
    Figure US20120326084A1-20121227-C00061
    Figure US20120326084A1-20121227-C00062
    Figure US20120326084A1-20121227-C00063
    Figure US20120326084A1-20121227-C00064
    Figure US20120326084A1-20121227-C00065
    Figure US20120326084A1-20121227-C00066
    Figure US20120326084A1-20121227-C00067
    Figure US20120326084A1-20121227-C00068
    Figure US20120326084A1-20121227-C00069
    Figure US20120326084A1-20121227-C00070
    Figure US20120326084A1-20121227-C00071
    Figure US20120326084A1-20121227-C00072
    Figure US20120326084A1-20121227-C00073
    Figure US20120326084A1-20121227-C00074
    Figure US20120326084A1-20121227-C00075
    Figure US20120326084A1-20121227-C00076
    Figure US20120326084A1-20121227-C00077
    Figure US20120326084A1-20121227-C00078
    Figure US20120326084A1-20121227-C00079
    Figure US20120326084A1-20121227-C00080
    Figure US20120326084A1-20121227-C00081
    Figure US20120326084A1-20121227-C00082
    Figure US20120326084A1-20121227-C00083
    Figure US20120326084A1-20121227-C00084
    Figure US20120326084A1-20121227-C00085
    Figure US20120326084A1-20121227-C00086
    Figure US20120326084A1-20121227-C00087
    Figure US20120326084A1-20121227-C00088
    Figure US20120326084A1-20121227-C00089
    Figure US20120326084A1-20121227-C00090
    Figure US20120326084A1-20121227-C00091
    Figure US20120326084A1-20121227-C00092
    Figure US20120326084A1-20121227-C00093
    Figure US20120326084A1-20121227-C00094
    Figure US20120326084A1-20121227-C00095
    Figure US20120326084A1-20121227-C00096
    Figure US20120326084A1-20121227-C00097
    Figure US20120326084A1-20121227-C00098
    Figure US20120326084A1-20121227-C00099
    Figure US20120326084A1-20121227-C00100
    Figure US20120326084A1-20121227-C00101
    Figure US20120326084A1-20121227-C00102
    Figure US20120326084A1-20121227-C00103
    Figure US20120326084A1-20121227-C00104
    Figure US20120326084A1-20121227-C00105
    Figure US20120326084A1-20121227-C00106
    Figure US20120326084A1-20121227-C00107
    Figure US20120326084A1-20121227-C00108
    Figure US20120326084A1-20121227-C00109
    Figure US20120326084A1-20121227-C00110
    Figure US20120326084A1-20121227-C00111
    Figure US20120326084A1-20121227-C00112
    Figure US20120326084A1-20121227-C00113
    Figure US20120326084A1-20121227-C00114
    Figure US20120326084A1-20121227-C00115
    Figure US20120326084A1-20121227-C00116
    Figure US20120326084A1-20121227-C00117
    Figure US20120326084A1-20121227-C00118
    Figure US20120326084A1-20121227-C00119
    Figure US20120326084A1-20121227-C00120
    Figure US20120326084A1-20121227-C00121
    Figure US20120326084A1-20121227-C00122
    Figure US20120326084A1-20121227-C00123
    Figure US20120326084A1-20121227-C00124
    Figure US20120326084A1-20121227-C00125
    Figure US20120326084A1-20121227-C00126
    Figure US20120326084A1-20121227-C00127
    Figure US20120326084A1-20121227-C00128
    Figure US20120326084A1-20121227-C00129
    Figure US20120326084A1-20121227-C00130
    Figure US20120326084A1-20121227-C00131
    Figure US20120326084A1-20121227-C00132
    Figure US20120326084A1-20121227-C00133
    Figure US20120326084A1-20121227-C00134
    Figure US20120326084A1-20121227-C00135
    Figure US20120326084A1-20121227-C00136
    Figure US20120326084A1-20121227-C00137
    Figure US20120326084A1-20121227-C00138
    Figure US20120326084A1-20121227-C00139
    Figure US20120326084A1-20121227-C00140
    Figure US20120326084A1-20121227-C00141
    Figure US20120326084A1-20121227-C00142
    Figure US20120326084A1-20121227-C00143
    Figure US20120326084A1-20121227-C00144
    Figure US20120326084A1-20121227-C00145
    Figure US20120326084A1-20121227-C00146
    Figure US20120326084A1-20121227-C00147
    Figure US20120326084A1-20121227-C00148
    Figure US20120326084A1-20121227-C00149
    Figure US20120326084A1-20121227-C00150
    Figure US20120326084A1-20121227-C00151
    Figure US20120326084A1-20121227-C00152
    Figure US20120326084A1-20121227-C00153
    Figure US20120326084A1-20121227-C00154
    Figure US20120326084A1-20121227-C00155
    Figure US20120326084A1-20121227-C00156
    Figure US20120326084A1-20121227-C00157
    Figure US20120326084A1-20121227-C00158
    Figure US20120326084A1-20121227-C00159
    The following abbreviations are used: (n, m, m′, z: each, independently of one another, 1, 2, 3, 4, 5 or 6; (O)CmH2m+1 means OCmH2m+1 or CmH2m+1)
  • The liquid-crystal mixtures which can be used in accordance with the invention are prepared in a manner which is conventional per se. In general, the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing.
  • By means of suitable additives, the liquid-crystal phases according to the invention can be modified in such a way that they can be employed in any type of, for example, ECB, VAN, IPS, GH or ASM-VA LCD display that has been disclosed to date.
  • The dielectrics may also comprise further additives known to the person skilled in the art and described in the literature, such as, for example, UV absorbers, antioxidants, nanoparticles and free-radical scavengers. For example, 0-15% of pleochroic dyes, stabilisers or chiral dopants may be added. Suitable stabilisers for the mixtures according to the invention are, in particular, those listed in Table B.
  • For example, 0-15% of pleochroic dyes may be added, furthermore conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf., for example, Haller et al., Mol. Cryst. Liq. Cryst. Volume 24, pages 249-258 (1973)), may be added in order to improve the conductivity or substances may be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. Substances of this type are described, for example, in DE-A 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430 and 28 53 728.
  • Table B shows possible dopants which can be added to the mixtures according to the invention. If the mixtures comprise a dopant, it is employed in amounts of 0.01-4% by weight, preferably 0.1-1.0% by weight.
  • TABLE B
    Figure US20120326084A1-20121227-C00160
      C 15
    Figure US20120326084A1-20121227-C00161
      CB 15
    Figure US20120326084A1-20121227-C00162
      CM 21
    Figure US20120326084A1-20121227-C00163
      R/S-811
    Figure US20120326084A1-20121227-C00164
      CM 44
    Figure US20120326084A1-20121227-C00165
      CM 45
    Figure US20120326084A1-20121227-C00166
      CM 47
    Figure US20120326084A1-20121227-C00167
      CN
    Figure US20120326084A1-20121227-C00168
      R/S-1011
    Figure US20120326084A1-20121227-C00169
      R/S-2011
    Figure US20120326084A1-20121227-C00170
      R/S-3011
    Figure US20120326084A1-20121227-C00171
      R/S-4011
    Figure US20120326084A1-20121227-C00172
      R/S-5011
  • Stabilisers which can be added, for example, to the mixtures according to the invention in amounts of up to 10% by weight, based on the total amount of the mixture, preferably 0.01 to 6% by weight, in particular 0.1 to 3% by weight, are shown below in Table C. Preferred stabilisers are, in particular, BHT derivatives, for example 2,6-di-tert-butyl-4-alkylphenols, and Tinuvin 770.
  • TABLE C
    Figure US20120326084A1-20121227-C00173
    Figure US20120326084A1-20121227-C00174
    Figure US20120326084A1-20121227-C00175
    Figure US20120326084A1-20121227-C00176
    Figure US20120326084A1-20121227-C00177
      n = 1, 2, 3, 4, 5, 6 or 7
    Figure US20120326084A1-20121227-C00178
    Figure US20120326084A1-20121227-C00179
    Figure US20120326084A1-20121227-C00180
    Figure US20120326084A1-20121227-C00181
    Figure US20120326084A1-20121227-C00182
    Figure US20120326084A1-20121227-C00183
    Figure US20120326084A1-20121227-C00184
    Figure US20120326084A1-20121227-C00185
    Figure US20120326084A1-20121227-C00186
    Figure US20120326084A1-20121227-C00187
    n = 1, 2, 3, 4, 5, 6 or 7
    Figure US20120326084A1-20121227-C00188
    Figure US20120326084A1-20121227-C00189
    Figure US20120326084A1-20121227-C00190
    Figure US20120326084A1-20121227-C00191
    Figure US20120326084A1-20121227-C00192
    Figure US20120326084A1-20121227-C00193
    Figure US20120326084A1-20121227-C00194
    Figure US20120326084A1-20121227-C00195
    Figure US20120326084A1-20121227-C00196
    Figure US20120326084A1-20121227-C00197
    Figure US20120326084A1-20121227-C00198
    Figure US20120326084A1-20121227-C00199
    Figure US20120326084A1-20121227-C00200
    Figure US20120326084A1-20121227-C00201
    Figure US20120326084A1-20121227-C00202
    Figure US20120326084A1-20121227-C00203
    Figure US20120326084A1-20121227-C00204
    Figure US20120326084A1-20121227-C00205
    Figure US20120326084A1-20121227-C00206
    Figure US20120326084A1-20121227-C00207
    Figure US20120326084A1-20121227-C00208
    Figure US20120326084A1-20121227-C00209
    Figure US20120326084A1-20121227-C00210
    Figure US20120326084A1-20121227-C00211
    Figure US20120326084A1-20121227-C00212
    Figure US20120326084A1-20121227-C00213
    Figure US20120326084A1-20121227-C00214
    Figure US20120326084A1-20121227-C00215
    (n = 1-12)
  • Especially preferred reactive mesogens for use in the mixtures according to the invention, preferably in PSA and PS-VA applications are shown in Table D below:
  • TABLE D
    Figure US20120326084A1-20121227-C00216
      RM-1
    Figure US20120326084A1-20121227-C00217
      RM-2
    Figure US20120326084A1-20121227-C00218
      RM-3
    Figure US20120326084A1-20121227-C00219
      RM-4
    Figure US20120326084A1-20121227-C00220
      RM-5
    Figure US20120326084A1-20121227-C00221
      RM-6
    Figure US20120326084A1-20121227-C00222
      RM-7
    Figure US20120326084A1-20121227-C00223
      RM-8
    Figure US20120326084A1-20121227-C00224
      RM-9
    Figure US20120326084A1-20121227-C00225
      RM-10
    Figure US20120326084A1-20121227-C00226
      RM-11
    Figure US20120326084A1-20121227-C00227
      RM-12
    Figure US20120326084A1-20121227-C00228
      RM-13
    Figure US20120326084A1-20121227-C00229
      RM-14
    Figure US20120326084A1-20121227-C00230
      RM-15
    Figure US20120326084A1-20121227-C00231
      RM-16
    Figure US20120326084A1-20121227-C00232
      RM-17
    Figure US20120326084A1-20121227-C00233
      RM-18
    Figure US20120326084A1-20121227-C00234
      RM-19
    Figure US20120326084A1-20121227-C00235
      RM-20
    Figure US20120326084A1-20121227-C00236
      RM-21
    Figure US20120326084A1-20121227-C00237
      RM-22
    Figure US20120326084A1-20121227-C00238
      RM-23
    Figure US20120326084A1-20121227-C00239
      RM-24
    Figure US20120326084A1-20121227-C00240
      RM-25
    Figure US20120326084A1-20121227-C00241
      RM-26
    Figure US20120326084A1-20121227-C00242
      RM-27
    Figure US20120326084A1-20121227-C00243
      RM-28
    Figure US20120326084A1-20121227-C00244
      RM-29
    Figure US20120326084A1-20121227-C00245
      RM-30
    Figure US20120326084A1-20121227-C00246
      RM-31
    Figure US20120326084A1-20121227-C00247
      RM-32
  • The following examples are intended to explain the invention without restricting it. In the examples, m.p. denotes the melting point and C denotes the clearing point of a liquid-crystalline substance in degrees Celsius; boiling points are denoted by b.p. Furthermore:
  • C denotes crystalline solid state, S denotes smectic phase (the index denotes the phase type), N denotes nematic state, Ch denotes cholesteric phase, I denotes isotropic phase, Tg denotes glass transition temperature. The number between two symbols indicates the conversion temperature in degrees Celsius.
  • The host mixture used for determination of the physical data of the compounds of the formula I is the commercial mixture ZLI-4792 (Merck KGaA). The physical data of the compound to be investigated are obtained from the change in the dielectric constants of the host mixture after addition of the compound to be investigated and extrapolation to 100% of the compound employed. In general, 10% of the compound to be investigated are dissolved in the host mixture, depending on the solubility.
  • Unless indicated otherwise, parts or percent data denote parts by weight or percent by weight.
  • Above and below,
    • V0 denotes the threshold voltage, capacitive [V] at 20° C.
    • Δn denotes the optical anisotropy measured at 20° C. and 589 nm
    • Δ∈ denotes the dielectric anisotropy at 20° C. and 1 kHz
    • cl.p. denotes the clearing point [° C.]
    • K1 denotes the elastic constant, “splay” deformation at 20° C. [pN]
    • K3 denotes the elastic constant, “bend” deformation at 20° C. [pN]
    • γ1 denotes the rotational viscosity measured at 20° C. [mPa·s], determined by the rotation method in a magnetic field
    • LTS denotes the low-temperature stability (nematic phase), determined in test cells
  • The display used for measurement of the threshold voltage has two plane-parallel outer plates at a separation of 20 μm and electrode layers with overlying alignment layers of SE-1211 (Nissan Chemicals) on the insides of the outer plates, which effect a homeotropic alignment of the liquid crystals.
  • All concentrations in this application relate to the corresponding mixture or mixture component, unless explicitly indicated otherwise. All physical properties are determined as described in “Merck Liquid Crystals, Physical Properties of Liquid Crystals”, status November 1997, Merck KGaA, Germany, and apply for a temperature of 20° C., unless explicitly indicated otherwise.
  • MIXTURE EXAMPLES Example M1
  • CY-3-O2 22.50% Clearing point [° C.]: 76.5
    CCY-3-O2 10.00% Δn [589 nm, 20° C.]: 0.0917
    CCY-4-O2 2.00% Δε [1 kHz, 20° C.]: −2.9
    CPY-2-O2 7.50% ε [1 kHz, 20° C.]: 6.3
    CPY-3-O2 10.00% K3 [pN, 20° C,]: 14.4
    CCH-34 6.00% K3/K1 [20° C.]: 1.04
    CCH-23 22.00% γ1 [mPa.s, 20° C.]: 108
    CCP-3-3 5.00% V0 [20° C., V]: 2.35
    CCP-3-1 5.00% LTS [bulk, −30° C.]: >1000 h
    BCH-32 4.00%
    C-1V-V1 3.00%
    CBC-33 3.00%
  • Example M2
  • CY-3-O4 29.00% Clearing point [° C.]: 80
    CCY-3-O3  5.00% Δn [589 nm, 20° C.]: 0.0953
    CPY-2-O2  9.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-3-O2 10.00% ε [1 kHz, 20° C.]: 6.4
    CC-3-V1 10.00% K3 [pN, 20° C.]: 15.0
    CCP-V-1 12.00% K3/K1 [20° C.]: 1.07
    CCP-V2-1 12.00% γ1 [mPa · s, 20° C.]: 118
    CCH-34 11.00% V0 [20° C., V]: 2.38
    Figure US20120326084A1-20121227-C00248
     2.00% LTS [bulk, −20° C.]: >1000 h
  • Example M3
  • CY-3-O4 29.00% Clearing point [° C.]: 80.5
    CCY-3-O3 5.00% Δn [589 nm, 20° C.]: 0.0963
    CPY-2-O2 9.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-3-O2 10.00% ε [1 kHz, 20° C.]: 6.3
    CC-3-V1 12.00% K3 [pN, 20° C,]: 15.6
    CCP-V-1 14.00% K3/K1 [20° C.]: 1.11
    CCP-V2-1 8.00% γ1 [mPa.s, 20° C.]: 117
    CCH-34 11.00% V0 [20° C., V]: 2.43
    C-1V-V1 2.00% LTS [bulk, −20° C.]: >1000 h
  • Example M4
  • CY-3-O4 30.00% Clearing point [° C.]: 80.0
    CCY-3-O3 8.00% Δn [589 nm, 20° C.]: 0.0955
    CPY-2-O2 7.00% Δε [1 kHz, 20° C.]: −3.1
    CPY-3-O2 10.00% ε [1 kHz, 20° C.]: 6.6
    CC-3-V1 12.00% K3 [pN, 20° C,]: 15.7
    CCP-V-1 14.00% K3/K1 [20° C.]: 1.11
    CCP-V2-1 7.00% γ1 [mPa.s, 20° C.]: 122
    CCH-34 10.00% V0 [20° C., V]: 2.37
    C-1V-V1 2.00%
  • Example M5
  • CY-3-O2 22.00% Clearing point [° C.]: 79.5
    CY-5-O2  4.00% Δn [589 nm, 20° C.]: 0.0967
    CCY-3-O2  6.00% Δε [1 kHz, 20° C.]: −3.1
    CCY-4-O2  4.00% ε [1 kHz, 20° C.]: 6.5
    CPY-2-O2  8.00% K3 [pN, 20° C.]: 15.9
    CPY-3-O2  9.00% K3/K1 [20° C.]: 1.09
    CCH-34 10.00% γ1 [mPa · s, 20° C.]: 115
    CCH-35  5.00% γ1/K3 [mPa · s/pN, 20° C.]: 7.2
    CC-3-V1 11.00% V0 [20° C., V]: 2.41
    CCP-3-3  6.00% LTS [bulk, −20° C.]: >1000 h
    CCP-3-1  4.00%
    BCH-32  6.00%
    PCH-301  3.00%
    Figure US20120326084A1-20121227-C00249
     2.00%
  • Example M6
  • CY-3-O2 22.50% Clearing point [° C.]: 80.0
    CCY-3-O2 10.00% Δn [589 nm, 20° C.]: 0.0947
    CCY-4-O2 3.50% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 7.00% ε [1 kHz, 20° C.]: 6.4
    CPY-3-O2 10.00% K3 [pN, 20° C,]: 15.5
    CCH-34 3.00% K3/K1 [20° C.]: 1.17
    CCH-23 22.00% γ1 [mPa.s/pN, 20° C.]: 111
    CCP-3-3 7.00% γ1/K3 [mPa.s, 20° C.]: 7.2
    CCP-3-1 7.00% V0 [20° C., V]: 2.39
    BCH-32 5.00% LTS [bulk, −20° C.]: >1000 h
    C-1V-V1 3.00%
  • Example M7
  • CY-3-O2 22.50% Clearing point [° C.]: 80.0
    CCY-3-O2 10.00% Δn [589 nm, 20° C.]: 0.0941
    CCY-4-O2 2.50% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 8.00% ε [1 kHz, 20° C.]: 6.4
    CPY-3-O2 10.00% K3 [pN, 20° C,]: 15.3
    CCH-34 6.00% K3/K1 [20° C.]: 1.07
    CCH-23 22.00% γ1 [mPa.s/pN, 20° C.]: 110
    CCP-3-3 6.00% γ1/K3 [mPa.s, 20° C.]: 7.2
    CCP-3-1 6.00% V0 [20° C., V]: 2.38
    BCH-32 5.00% LTS [bulk, −20° C.]: >1000 h
    C-1V-V1 2.00%
  • Example M8
  • CY-3-O2 14.00% Clearing point [° C.]: 75.5
    CCY-3-O2  8.00% Δn [589 nm, 20° C.]: 0.0965
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 10.00% ε [1 kHz, 20° C.]: 6.4
    CPY-3-O2 10.00% K3 [pN, 20° C.]: 15.0
    PYP-2-3  4.00% K3/K1 [20° C.]: 1.15
    CC-3-V 40.00% γ1 [mPa · s, 20° C.]: 83
    CCP-V-1  2.00% γ1/K3 [mPa · s/pN, 20° C.]: 5.5
    Figure US20120326084A1-20121227-C00250
     2.00% V0 [20° C., V]: 2.37
  • Example M9
  • CY-3-O2 15.00% Clearing point [° C.]: 75.5
    CCY-3-O2 9.00% Δn [589 nm, 20° C.]: 0.0954
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 9.00% ε [1 kHz, 20° C.]: 6.5
    CPY-3-O2 10.00% K3 [20° C., pN]: 15.5
    PYP-2-3 3.00% K3/K1 [20° C.]: 1.18
    CC-3-V 42.00% γ1 [mPa.s, 20° C.]: 81
    C-1V-V1 2.00% V0 [20° C., V]: 2.39
  • Example M10
  • CY-3-O2 14.00% Clearing point [° C.]: 76.5
    CCY-3-O2 8.50% Δn [589 nm, 20° C.]: 0.0970
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 9.50% ε [1 kHz, 20° C.]: 6.4
    CPY-3-O2 10.00% K3 [pN, 20° C,]: 15.6
    PYP-2-3 4.00% K3/K1 [20° C.]: 1.18
    CC-3-V 42.00% γ1 [mPa.s, 20° C.]: 82
    C-1V-V1 2.00% V0 [20° C., V]: 2.41
  • Example M11
  • CY-3-O2 14.00% Clearing point [° C.]: 76.0
    CCY-3-O2 8.50% Δn [589 nm, 20° C.]: 0.0957
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 9.50% ε [1 kHz, 20° C.]: 6.4
    CPY-3-O2 10.00% K3 [pN, 20° C,]: 15.3
    PYP-2-3 4.00% K3/K1 [20° C.]: 1.16
    CC-3-V 42.00% γ1 [mPa.s, 20° C.]: 81
    C-2-5 2.00% V0 [20° C., V]: 2.38
  • Example M12
  • CY-3-O2 14.00% Clearing point [° C.]: 76.0
    CCY-3-O2 8.50% Δn [589 nm, 20° C.]: 0.0955
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 9.50% ε [1 kHz, 20° C.]: 6.4
    CPY-3-O2 10.00% K3 [pN, 20° C,]: 15.4
    PYP-2-3 4.00% K3/K1 [20° C.]: 1.17
    CC-3-V 42.00% γ1 [mPa.s, 20° C.]: 81
    C-5-V 2.00% V0 [20° C., V]: 2.39
  • Example M13
  • CY-3-O2 14.00% Clearing point [° C.]: 74.0
    CCY-3-O2 8.50% Δn [589 nm, 20° C.]: 0.0960
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 9.50% ε [1 kHz, 20° C.]: 6.5
    CPY-3-O2 10.00% K3 [pN, 20° C,]: 15.0
    PYP-2-3 4.00% K3/K1 [20° C.]: 1.17
    CC-3-V 40.50% γ1 [mPa.s, 20° C.]: 79
    C-5-XF 3.50% V0 [20° C., V]: 2.38
  • Example M14
  • CY-3-O2 16.00% Clearing point [° C.]: 72.0
    CCY-3-O2 6.00% Δn [589 nm, 20° C.]: 0.0925
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −2.9
    CPY-2-O2 10.00% ε [1 kHz, 20° C.]: 6.4
    CPY-3-O2 11.00% K3 [pN, 20° C,]: 14.1
    CC-3-V 41.00% K3/K1 [20° C.]: 1.15
    C-1V-V1 3.00% γ1 [mPa.s, 20° C.]: 78
    CPGP-4-3 3.00% V0 [20° C., V]: 2.33
  • Example M15
  • CY-3-O2 17.50% Clearing point [° C.]: 72.0
    CCY-3-O2 6.50% Δn [589 nm, 20° C.]: 0.0933
    CLY-3-O2 10.00% Δε [1 kHz, 20° C.]: −3.0
    CPY-2-O2 7.50% ε [1 kHz, 20° C.]: 6.5
    CPY-3-O2 11.00% K3 [pN, 20° C,]: 14.4
    PYP-2-3 3.50% K3/K1 [20° C.]: 1.15
    CC-3-V 40.00% γ1 [mPa.s, 20° C.]: 78
    C-1V-V1 2.00% V0 [20° C., V]: 2.31
    CCVC-3-V 2.00%

Claims (14)

1. Liquid-crystalline medium based on a mixture of polar compounds, characterised in that it comprises at least one compound of the formula I,
Figure US20120326084A1-20121227-C00251
in which
R1 and R1* each, independently of one another, denote an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each be replaced, independently of one another, by —C≡C—, —CF2O—, —CH═CH—,
Figure US20120326084A1-20121227-C00252
—O—, —CO—O—, —O—CO— in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, and
ring A denotes a 1,4-cyclohexylene ring or 1,4-cyclohexenylene ring, in which, in addition, one or two CH2 groups may be replaced by —O— and/or —S—.
2. Liquid-crystalline medium according to claim 1, characterised in that it additionally comprises one or more compounds selected from the group of the compounds of the formulae IIA, IIB and IIC,
Figure US20120326084A1-20121227-C00253
in which
R2A, R2B and R2C each, independently of one another, denote H, an alkyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may be replaced by —O—, —S—,
Figure US20120326084A1-20121227-C00254
—C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another,
L1-4 each, independently of one another, denote F or Cl,
Z2 and Z2′ each, independently of one another, denote a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —CF═CF—, —CH═CHCH2O—,
p denotes 1 or 2,
q denotes 0 or 1, and
v denotes 1 to 6.
3. Liquid-crystalline medium according to claim 1, characterised in that it additionally comprises one or more compounds of the formula III,
Figure US20120326084A1-20121227-C00255
in which
R31 and R32 each, independently of one another, denote a straight-chain alkyl, alkoxyalkyl or alkoxy radical having up to 12 C atoms, and
Figure US20120326084A1-20121227-C00256
denotes
Figure US20120326084A1-20121227-C00257
Z3 denotes a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —C4H9—, —CF═CF—.
4. Liquid-crystalline medium according to claim 1, characterised in that the medium comprises at least compound of the formulae I-1 to I-8,
Figure US20120326084A1-20121227-C00258
in which
alkyl and alkyl* each, independently of one another, denote a straight-chain or branched alkyl radical having 1-8 C atoms,
alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-8 C atoms,
alkoxy and alkoxy* each, independently of one another, denote a straight-chain alkoxy radical having 1-8 C atoms.
5. Liquid-crystalline medium according claim 1, characterised in that the medium additionally comprises at least one compound of the formulae L-1 to L-11,
Figure US20120326084A1-20121227-C00259
Figure US20120326084A1-20121227-C00260
in which
R, R1 and R2 each, independently of one another denote H, an alkyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may be replaced by —O—, —S—,
Figure US20120326084A1-20121227-C00261
—C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another,
alkyl denotes an alkyl radical having 1-6 C atoms, and
s denotes 1 or 2.
6. Liquid-crystalline medium according to claim 1, characterised in that the medium additionally comprises one or more terphenyls of the formulae T-1 to T-21,
Figure US20120326084A1-20121227-C00262
Figure US20120326084A1-20121227-C00263
Figure US20120326084A1-20121227-C00264
in which
R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms, and
m denotes 1-6.
7. Liquid-crystalline medium according to claim 1, characterised in that the medium additionally comprises one or more compounds of the formulae O-1 to O-16,
Figure US20120326084A1-20121227-C00265
Figure US20120326084A1-20121227-C00266
in which
R1 and R2 each, independently of one another, denote H, an alkyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may be replaced by —O—, —S—,
Figure US20120326084A1-20121227-C00267
—C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another.
8. Liquid-crystalline medium according to claim 1, characterised in that the medium additionally comprises one or more indane compounds of the formula In,
Figure US20120326084A1-20121227-C00268
in which
R11, R12, R13 denote a straight-chain alkyl, alkoxy, alkoxyalkyl or alkenyl radical having 1-5 C atoms,
R12 and R13 additionally also denote halogen,
Figure US20120326084A1-20121227-C00269
denotes
Figure US20120326084A1-20121227-C00270
i denotes 0, 1 or 2.
9. Liquid-crystalline medium according to claim 1, characterised in that the proportion of compounds of the formula I in the mixture as a whole is ≧1% by weight.
10. Process for the preparation of a liquid-crystalline medium according to claim 1, characterised in that at least one compound of the formula I is mixed with at least one further liquid-crystalline compound, and additives are optionally added.
11. An electro-optical display, which contains, as dielectric, a liquid-crystalline medium according to claim 1.
12. Electro-optical display having active-matrix addressing, characterised in that it contains, as dielectric, a liquid-crystalline medium according to claim 1.
13. Electro-optical display according to claim 12, characterised in that it is a VA, PSA, PS-VA, PALC, FFS or IPS display.
14. Compounds of the formulae
Figure US20120326084A1-20121227-C00271
in which
alkyl denotes a straight-chain or branched alkyl radical having 1-8 C atoms.
US13/582,543 2010-03-04 2011-02-10 Liquid-crystalline medium Expired - Fee Related US8877092B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102010010333 2010-03-04
DE102010010333 2010-03-04
DE102010010333.0 2010-03-04
PCT/EP2011/000637 WO2011107213A1 (en) 2010-03-04 2011-02-10 Liquid-crystalline medium

Publications (2)

Publication Number Publication Date
US20120326084A1 true US20120326084A1 (en) 2012-12-27
US8877092B2 US8877092B2 (en) 2014-11-04

Family

ID=43778285

Family Applications (1)

Application Number Title Priority Date Filing Date
US13/582,543 Expired - Fee Related US8877092B2 (en) 2010-03-04 2011-02-10 Liquid-crystalline medium

Country Status (7)

Country Link
US (1) US8877092B2 (en)
EP (1) EP2542647B1 (en)
JP (1) JP5788418B2 (en)
DE (1) DE102011010851A1 (en)
GB (1) GB2491087B (en)
TW (1) TWI577654B (en)
WO (1) WO2011107213A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120305843A1 (en) * 2010-02-09 2012-12-06 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystalline medium
US20150197691A1 (en) * 2013-05-22 2015-07-16 Dic Corporation Liquid crystal display device
US20150299574A1 (en) * 2014-04-22 2015-10-22 Merck Patent Gmbh Liquid crystalline medium
KR20160110899A (en) * 2015-03-13 2016-09-22 메르크 파텐트 게엠베하 Liquid crystal medium
US9464229B2 (en) 2013-05-22 2016-10-11 Dic Corporation Liquid crystal display device
US20170362506A1 (en) * 2015-03-13 2017-12-21 Merck Patent Gmbh Liquid-crystalline medium
US10035955B2 (en) 2014-07-29 2018-07-31 Dic Corporation Liquid-crystal display element
US10081765B2 (en) 2012-10-24 2018-09-25 Merck Patent Gmbh Liquid-crystalline medium
US10414980B2 (en) 2014-07-29 2019-09-17 Dic Corporation Liquid-crystal display
US10421906B2 (en) 2014-07-29 2019-09-24 Dic Corporation Liquid-crystal display element
US10437107B2 (en) 2013-10-30 2019-10-08 Dic Corporation Liquid-crystal display element

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012072201A1 (en) * 2010-12-01 2012-06-07 Merck Patent Gmbh Liquid-crystalline medium
CN102898272B (en) * 2012-10-13 2015-10-07 江苏和成显示科技股份有限公司 Containing six hydrogen indenes class novel liquid crystals and composition thereof and application in a liquid crystal display
CN102898273B (en) * 2012-10-13 2015-10-14 江苏和成显示科技股份有限公司 Containing six hydrogen pentalene class novel liquid crystal compounds and composition thereof and application
US20150337200A1 (en) * 2012-10-23 2015-11-26 Dic Corporation Liquid crystal composition, liquid crystal display element, and liquid crystal display
JP7086914B2 (en) * 2014-03-17 2022-06-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Liquid crystal medium
JP2015044998A (en) * 2014-09-16 2015-03-12 Dic株式会社 Liquid crystal composition, liquid crystal display element, and liquid crystal display
US20180016500A1 (en) * 2015-02-25 2018-01-18 Jnc Corporation Liquid crystal composition and liquid crystal display device
JPWO2016152405A1 (en) * 2015-03-26 2017-04-27 Dic株式会社 Liquid crystal compound, liquid crystal composition and display element
CN107557022B (en) * 2016-07-01 2023-09-12 江苏和成显示科技有限公司 Liquid crystal composition containing single ring compound and display device thereof
JP2017214589A (en) * 2017-07-03 2017-12-07 Dic株式会社 Liquid crystal composition, liquid crystal display element and liquid crystal display
TWI786218B (en) * 2017-11-21 2022-12-11 日商迪愛生股份有限公司 Liquid crystal composition and liquid crystal display element

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172720B1 (en) * 1997-05-23 2001-01-09 Kent Displays Incorporated Low viscosity liquid crystal material
US6366330B1 (en) * 1997-05-23 2002-04-02 Kent Displays Incorporated Cholesteric liquid crystal display that prevents image sticking

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795849A (en) 1972-02-26 1973-08-23 Merck Patent Gmbh MODIFIED NEMATIC PHASES
US3814700A (en) 1972-08-03 1974-06-04 Ibm Method for controllably varying the electrical properties of nematic liquids and dopants therefor
DE2450088A1 (en) 1974-10-22 1976-04-29 Merck Patent Gmbh Liquid crystalline dielectrics for electronic components - contg biphenylyl carboxylic acid phenyl ester or benzoic acid biphenylyl ester components
DE2637430A1 (en) 1976-08-20 1978-02-23 Merck Patent Gmbh Heterocyclic diaza cpd. in liquid crystalline dielectric - for electrooptical registration devices, giving stable orientation parallel to electrode surfaces
DE2853728A1 (en) 1978-12-13 1980-07-17 Merck Patent Gmbh LIQUID CRYSTALLINE CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF, ITS CONTAINING DIELECTRICS AND ELECTRO-OPTICAL DISPLAY ELEMENT
FR2595157B1 (en) 1986-02-28 1988-04-29 Commissariat Energie Atomique CELL WITH A DOUBLE LAYER OF LIQUID CRYSTAL, USING THE ELECTRICALLY CONTROLLED BIREFRINGENCE EFFECT AND METHOD FOR MANUFACTURING A UNIAXIC NEGATIVE ANISOTROPY ANISOTROPY MEDIUM FOR USE IN THIS CELL
DE4034123A1 (en) * 1990-10-26 1992-04-30 Merck Patent Gmbh Partially fluorinated alkane derivs. - useful as components of liq. crystal media for electro=optical displays
US5342544A (en) 1991-10-28 1994-08-30 Asahi Denka Kogyo Kabushiki Kaisha Liquid crystal composition
JP3076425B2 (en) * 1991-11-13 2000-08-14 旭電化工業株式会社 Carboxylic acid mixture and nematic liquid crystal composition
JP3215465B2 (en) * 1991-10-28 2001-10-09 旭電化工業株式会社 Liquid crystal composition
US6168839B1 (en) 1996-12-19 2001-01-02 Chisso Corporation Cyclohexane derivatives, liquid-crystal composition, and liquid-crystal display element
JPH10218801A (en) * 1997-02-07 1998-08-18 Chisso Corp Liquid crystalline compound, liquid crystal composition and liquid crystal displaying element
DE19941567A1 (en) * 1998-09-05 2000-04-20 Merck Patent Gmbh New liquid crystal compounds containing 3-hydroxyacrylic acid ester units, having high clear point, dielectric anisotropy and double refraction, useful e.g. in displays or (electro)optical components
CN1327279C (en) 2002-02-04 2007-07-18 夏普株式会社 Liquid crystal display and method of manufacturing the same
EP1378557B1 (en) 2002-07-06 2007-02-21 MERCK PATENT GmbH Liquid crystalline medium
US7704567B2 (en) 2003-10-17 2010-04-27 Merck Patent Gmbh Liquid-crystalline medium comprising fluorinated indane compound
KR20060059192A (en) * 2004-11-26 2006-06-01 메르크 파텐트 게엠베하 Liquid crystal medium
DE102005058541A1 (en) * 2005-12-08 2007-06-14 Merck Patent Gmbh Liquid crystalline medium
KR20110005272A (en) * 2008-04-22 2011-01-17 메르크 파텐트 게엠베하 Liquid crystalline medium

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172720B1 (en) * 1997-05-23 2001-01-09 Kent Displays Incorporated Low viscosity liquid crystal material
US6366330B1 (en) * 1997-05-23 2002-04-02 Kent Displays Incorporated Cholesteric liquid crystal display that prevents image sticking

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120305843A1 (en) * 2010-02-09 2012-12-06 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystalline medium
US9777216B2 (en) * 2010-02-09 2017-10-03 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystalline medium
US10472569B2 (en) 2012-10-24 2019-11-12 Merck Patent Gmbh Liquid-crystalline medium
US10081765B2 (en) 2012-10-24 2018-09-25 Merck Patent Gmbh Liquid-crystalline medium
US20150197691A1 (en) * 2013-05-22 2015-07-16 Dic Corporation Liquid crystal display device
US9376618B2 (en) * 2013-05-22 2016-06-28 Dic Corporation Liquid crystal display device
US9464229B2 (en) 2013-05-22 2016-10-11 Dic Corporation Liquid crystal display device
US10437107B2 (en) 2013-10-30 2019-10-08 Dic Corporation Liquid-crystal display element
US20150299574A1 (en) * 2014-04-22 2015-10-22 Merck Patent Gmbh Liquid crystalline medium
CN105131976A (en) * 2014-04-22 2015-12-09 默克专利股份有限公司 Liquid crystalline medium
CN110577838A (en) * 2014-04-22 2019-12-17 默克专利股份有限公司 Liquid-crystalline medium
US10421906B2 (en) 2014-07-29 2019-09-24 Dic Corporation Liquid-crystal display element
US10414980B2 (en) 2014-07-29 2019-09-17 Dic Corporation Liquid-crystal display
US10035955B2 (en) 2014-07-29 2018-07-31 Dic Corporation Liquid-crystal display element
US20170362506A1 (en) * 2015-03-13 2017-12-21 Merck Patent Gmbh Liquid-crystalline medium
KR20160110899A (en) * 2015-03-13 2016-09-22 메르크 파텐트 게엠베하 Liquid crystal medium
KR102587314B1 (en) 2015-03-13 2023-10-12 메르크 파텐트 게엠베하 Liquid crystal medium
US11884863B2 (en) * 2015-03-13 2024-01-30 Merck Patent Gmbh Liquid-crystalline medium

Also Published As

Publication number Publication date
TW201139332A (en) 2011-11-16
EP2542647B1 (en) 2015-09-16
GB2491087B (en) 2016-11-09
JP2013521350A (en) 2013-06-10
DE102011010851A1 (en) 2011-09-08
TWI577654B (en) 2017-04-11
JP5788418B2 (en) 2015-09-30
EP2542647A1 (en) 2013-01-09
US8877092B2 (en) 2014-11-04
GB2491087A (en) 2012-11-21
GB201217126D0 (en) 2012-11-07
WO2011107213A1 (en) 2011-09-09

Similar Documents

Publication Publication Date Title
US8877092B2 (en) Liquid-crystalline medium
US9777216B2 (en) Liquid crystalline medium
US8399073B2 (en) Liquid-crystal medium
US9951274B2 (en) Liquid-crystalline medium
US11214736B2 (en) Liquid-crystalline medium
US9580653B2 (en) Liquid-crystalline medium
US9234136B2 (en) Liquid-crystalline medium
US8475889B2 (en) Liquid-crystalline medium
US8277684B2 (en) Liquid-crystal medium
US7854970B2 (en) Liquid-crystalline medium
US8168081B2 (en) Liquid-crystalline medium
US7785677B2 (en) Liquid-crystalline medium
US20190390112A1 (en) Liquid-crystalline medium
US20160319194A1 (en) Liquid crystalline medium
US20150166890A1 (en) Liquid-crystalline medium
US7582337B2 (en) Liquid-crystalline medium
US20100301270A1 (en) Liquid-crystalline meduim
US11453824B2 (en) Liquid-crystalline medium
EP3130650B1 (en) Liquid-crystalline medium
US20180265784A1 (en) Liquid-crystalline medium

Legal Events

Date Code Title Description
AS Assignment

Owner name: MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KLASEN-MEMMER, MELANIE;REIFFENRATH, VOLKER;SCHNEIDER, KONSTANTIN;AND OTHERS;REEL/FRAME:028892/0725

Effective date: 20120705

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551)

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20221104